Compare FMNB & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FMNB | FTH |
|---|---|---|
| Founded | 1887 | N/A |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 857.4M | 860.0M |
| IPO Year | 2010 | 2021 |
| Metric | FMNB | FTH |
|---|---|---|
| Price | $14.82 | $27.76 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 532.5K | 149.1K |
| Earning Date | 04-22-2026 | N/A |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | ★ 18.85 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $279,922,000.00 | N/A |
| Revenue This Year | $52.63 | N/A |
| Revenue Next Year | $8.28 | N/A |
| P/E Ratio | $41.67 | ★ N/A |
| Revenue Growth | ★ 3.89 | N/A |
| 52 Week Low | $12.23 | $17.50 |
| 52 Week High | $15.50 | $37.90 |
| Indicator | FMNB | FTH |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | N/A |
| Support Level | $13.75 | N/A |
| Resistance Level | $14.97 | N/A |
| Average True Range (ATR) | 0.26 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 74.75 | 0.00 |
Farmers National Banc Corp is a financial holding company based in the U.S. Along with its subsidiaries, it operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The group offers a full range of commercial and retail banking services, including checking accounts, savings accounts, time deposit accounts, commercial, mortgage, and installment loans, safe deposit boxes, ATMs, internet banking, and other banking services. Additionally, it offers personal and corporate trust services in the areas of estate settlement, trust administration, employee benefit plans, and retirement services; insurance products, and other financial products and services. The group's reportable segments are Bank, which generates the maximum revenue, and Trust.
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.